Cardiovascular and cerebrovascular events in temporal relationship to intravenous glucocorticoid pulse therapy in patients with severe endocrine ophthalmopathy

Thyroid

Volumn 19, Issue 12, 2009, Pages 1431-1432

  Lendorf, Maria E ^a   Rasmussen, Åse Krogh ^a   Fledelius, Hans C ^a   Feldt Rasmussen, Ulla ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GLUCOCORTICOID; LEVOTHYROXINE; METHYLPREDNISOLONE; PROPRANOLOL; PROPYLTHIOURACIL;

ADULT; AGED; CASE REPORT; CLINICAL FEATURE; CUSHINGOID SYNDROME; DEPRESSION; DIPLOPIA; DRUG MEGADOSE; DRUG PULSE THERAPY; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; FEMALE; GOITER; GRAVES DISEASE; HEADACHE; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; PRIORITY JOURNAL; SYMPTOM; THYROTOXICOSIS;

AGED; CARDIOVASCULAR DISEASES; CEREBRAL INFARCTION; CORONARY THROMBOSIS; FATAL OUTCOME; FEMALE; GLUCOCORTICOIDS; GRAVES OPHTHALMOPATHY; HUMANS; INFUSIONS, INTRAVENOUS; METHYLPREDNISOLONE; MYOCARDIAL INFARCTION; PULMONARY EMBOLISM; YOUNG ADULT;

EID: 75449104456     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0069     Document Type: Letter

References (12)

1. Macchia PE, Bagattini M, Lupoli G, Vitale M, Vitale G, Fenzi G 2001 High-dose intravenous corticosteroid therapy for Graves' ophthalmopathy. J Endocrinol Invest 24:152-158.
2. Nagayama Y, Izumi M, Kiriyama T, Yokoyama N, Morita S, Kakezono F, Ohtakara S, Morimoto I, Okamotot S, Nagataki S 1987 Treatments of Graves' ophthalmopathy with highdose intravenous methylprednisolone pulse therapy. Acta Endocrinol (Copenh) 116:513-518.
3. Kauppinen-Mäkelin R, Karma A, Leinonen E, Löyttyniemi E, Salonen O, Sane T, SetäläK, Viikari J, Heufelder A, Vä- limäki M 2002 High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroid-associated ophthalmopathy. Acta Ophthalmol Scand 80:316-321.
4. Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'unto E, Rocchi R, Barbesino G, Mazzi B, Bartolomei MP, Lepri P, Cartei F, Nardi M, Pinchera A 2001 Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. J Clin Endocrinol Metab 86:3562-3567.
5. Tagami T, Tanaka K, Sugawa H, Nakamura H, Miyoshi Y,Mori T, Nakao K 1996 High-dose intravenous steroid pulse therapy in thyroid-associated ophthalmopathy. Endocr J 43:689-699.
6. Kahaly J, Pitz S, Hommel G, Dittmar M. 2005. Randomized, single blind trial of intravenous versus oral steroid monotherapy in Grave's orbitopathy. J Clin Endocrinol Metab 90:5234-5240.
7. Aktaran S, Akarsu E, Erbagci I, Araz M, Okumus S, Kartal M 2007 Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy. Int J Clin Pract 61:45-51.
8. Weissel M, Hauff W 2000 Fatal liver failure after high-dose glucocorticoid pulse therapy in a patient with severe thyroid eye disease. Thyroid 10:521.
9. Marino M, Morabito M, Brunetto MR, Bartalena L, Pinchera A, Marcocci C 2004 Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves' Ophthalmopathy. Thyroid 14:403-406.
10. Le Moli R, Baldeschi L, Saeed P, Regensburg N, Mourits MP, Wiersinga WM 2007 Determinants of liver damage associated intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy. Thyroid 17:357-362.
11. Owecki M, Sowinski J 2006 Cute myocardial infarction during high-dose methylprednisolone therapy for Graves' ophthalmopathy. Pharm World Sci 28:73-75.
12. Bartalena L, Baldeschi L, Dickinson AJ, Eckstein A, Kendall- Taylor P, Marcocci C, Mourits MP, Perros P, Boboridis K, Boschi A, Currò N, Daumerie C, Kahaly J, Krassas G, Lane CM, Lazarus JH, Marinò M, Nardi M, Neoh C, Orgiazzi J, Pearce S, Pinchera A, Pitz S, Salvi M, Sivelli P, Stahl M, von Arx G, Wiersinga WM 2008 Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. Thyroid 18:273-285.